E6-272
E6-272 is a human papillomavirus 16 (HPV 16) inhibitor. E6-272 induces Apoptosis. E6-272 inhibits the proliferation of HPV-positive cells. E6-272 can be used in the research of cervical cancer[1].
Product Specifications
CAS Number
945142-65-4
UNSPSC
12352005
Target
Apoptosis; HPV
Type
Reference compound
Related Pathways
Anti-infection; Apoptosis
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/e6-272.html
Purity
99.93
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(CC1=CC=C(C2=CC=CC=C2)C=C1)NC3CCN(CC3)CC4=CC=CC=C4
Molecular Formula
C26H28N2O
Molecular Weight
384.51
References & Citations
[1]Kumar A. Human papillomavirus-16 E6-positive cervical cancer attenuated by potent 2- (4-biphenylyl) -N- (1-ethyl-4-piperidinyl) acetamide second-generation analogs with improved binding affinity. Biotechnol Appl Biochem. 2024 Jul 22.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1593610 100 µL
Phospho-IRS1 (Ser616) Rabbit Polyclonal Antibody (APC-Cy5.5)
Sign In for Pricing
View Details MBS6316327-01 0.2 mL
LINGO-1, CT (S596) (LRRN6A) (Lingo1, Lern1, Lrrn6a, Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1, Leucine-rich repeat neuronal protein 1, Leucine-rich repeat neuronal protein 6A) (PE)
Sign In for Pricing
View Details MBS6316327-02 5x 0.2 mL
LINGO-1, CT (S596) (LRRN6A) (Lingo1, Lern1, Lrrn6a, Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1, Leucine-rich repeat neuronal protein 1, Leucine-rich repeat neuronal protein 6A) (PE)
Sign In for Pricing
View Details 044871 10 µg
GPX7, Recombinant, Human (Glutathione Peroxidase 7, CL683, GPx-7, GSHPx-7) discontinued
Sign In for Pricing
View Details